SYMQY
Price:
$0.637
Market Cap:
$4.88B
SymBio Pharmaceuticals Limited engages in the research and development, manufacturing, and marketing of pharmaceutical drugs in the areas of oncology and hematology in Japan. It is involved in the development of Treakisym SyB L-0501, an anti-cancer agent, which is marketed for the treatment of non-Hodgkin's lymphoma, multiple myeloma, and chronic lymphocytic leukemia under the TREAKISYM name; and is in the Phase III clinical trial to treat relapsed/refractory diffuse large B-cell lymphoma. The company also engages in the development of SyB L-1701, a ready-to-dilute formulation; and SyB L-1702, a rapid infusion liquid formulation. In addition, it is involved in the development of SyB L-1101, ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2016-08-05
Stock Exchange
OTC
Ticker
SYMQY
According to SymBio Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current ROE is -123.34%. This represents a change of 273.66% compared to the average of -33.01% of the last 4 quarters.
The mean historical ROE of SymBio Pharmaceuticals Limited over the last ten years is -54.24%. The current -123.34% ROE has changed 127.41% with respect to the historical average. Over the past ten years (40 quarters), SYMQY's ROE was at its highest in in the December 2021 quarter at 25.31%. The ROE was at its lowest in in the September 2017 quarter at -77.51%.
Average
-54.24%
Median
-57.77%
Minimum
-122.80%
Maximum
30.13%
Discovering the peaks and valleys of SymBio Pharmaceuticals Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 270.63%
Maximum Annual ROE = 30.13%
Minimum Annual Increase = -296.37%
Minimum Annual ROE = -122.80%
| Year | ROE | Change |
|---|---|---|
| 2024 | -91.33% | 235.46% |
| 2023 | -27.22% | -296.37% |
| 2022 | 13.86% | -53.98% |
| 2021 | 30.13% | -134.30% |
| 2020 | -87.82% | -11.70% |
| 2019 | -99.46% | 77.12% |
| 2018 | -56.15% | -54.27% |
| 2017 | -122.80% | 191.16% |
| 2016 | -42.17% | -28.99% |
| 2015 | -59.39% | 270.63% |
The current ROE of SymBio Pharmaceuticals Limited (SYMQY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-34.90%
5-year avg
-32.48%
10-year avg
-54.24%
SymBio Pharmaceuticals Limited’s ROE is greater than Goodness Growth Holdings, Inc. (-46.28%), greater than Ecofibre Limited (-51.27%), less than Elegance Optical International Holdings Limited (0%), less than Biocartis Group N.V. (203.74%), greater than Kiaro Holdings Corp. (-146.87%), greater than Herantis Pharma Oyj (-724.30%), greater than Karolinska Development AB (publ) (-11.56%), less than Taihe Group, Inc. (0.81%), greater than INNOCAN PHARMA Corp (-32.82%), less than Oncopeptides AB (publ) (9.01%),
| Company | ROE | Market cap |
|---|---|---|
| -46.28% | $61.05M | |
| -51.27% | $73.67M | |
| 0% | $63.38M | |
| 203.74% | $65.41M | |
| -146.87% | $442.00 | |
| -724.30% | $59.47M | |
| -11.56% | $68.85M | |
| 0.81% | $71.85M | |
| -32.82% | $30.86M | |
| 9.01% | $55.98M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SymBio Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like SymBio Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is SymBio Pharmaceuticals Limited's ROE?
How is the ROE calculated for SymBio Pharmaceuticals Limited (SYMQY)?
What is the highest ROE for SymBio Pharmaceuticals Limited (SYMQY)?
What is the 3-year average ROE for SymBio Pharmaceuticals Limited (SYMQY)?
What is the 5-year average ROE for SymBio Pharmaceuticals Limited (SYMQY)?
How does the current ROE for SymBio Pharmaceuticals Limited (SYMQY) compare to its historical average?